Tweets by @tcochrane
-
Get Ready to See This Globalization 'Elephant Chart' Over and Over Again https://t.co/J8hF6wwfDo -
Stem cell therapy gives hope to MS patients https://t.co/S4OseYtu5r
-
Sure Genomics wants to sell private genetic profiles for $2,500, but it’s really testing the FDA https://t.co/hfEDGcB4wJ?
-
Divergent mortality trends complicate market solution for longevity risk, says OECD | News | IPE https://t.co/IAaD4S6xeT
-
Coppola Comment: If only we could return to the glorious 1990s........ https://t.co/VgKWE58C2u
-
-
Goldman Flags $1 Trillion Reason for Fed to Go Slow on Rates https://t.co/EuoCcEXp1x
-
The world’s most reviled financial product may save your retirement https://t.co/x7ILzgRBjD via @qz
-
No Venture Capital Needed, or Wanted https://t.co/E15lNbmmKa
-
Researchers identify genes linked to the effects of mood and stress on longevity https://t.co/nO57Y5TIj8 via @medical_xpress
-
Genome editor CRISPR helps trace growth of embryos—and maybe cancer next https://t.co/s85N7YufW9
-
This Is Life at 400 https://t.co/to5bhhHAVk via @NautilusMag
-
The Untold Story Behind Saudi Arabia’s 41-Year U.S. Debt Secret https://t.co/XSkq8sVNRN
-
Climb in, float off, zone out: why floatation blows my mind — https://t.co/ekhpZPwzDP via @aeonmag
-
Paper Offers Guide to In-Plan Deferred Annuities https://t.co/ZRGwxXMh7w
-
These Are the Countries Where Millennials Will Work Themselves to Death https://t.co/fD99VBFZqF via @business
-
Angels pitcher Garrett Richards undergoes stem-cell procedure on injured elbow https://t.co/qal4pUY5f4
-
Immunotherapy Drug Approved for Treatment of Hodgkin Lymphoma https://t.co/vqzT2ZsYhf
-
F.D.A. Approves an Immunotherapy Drug for Bladder Cancer https://t.co/Et3oyU5U04
